期刊文献+

玻璃化冷冻和程序化冷冻人卵巢组织的效果 被引量:1

Effects of vitrification and programmed freezing on human ovarian tissue
下载PDF
导出
摘要 目的探讨玻璃化冷冻和程序化冷冻两种方法冻存人卵巢皮质的效果。方法收集因卵巢疾病患者需手术切除的卵巢组织标本,并随机分成玻璃化冷冻组、程序化冷冻组和新鲜对照组,分别进行组织学分析、窦前卵泡的分类计数和卵巢皮质的培养,比较3组卵巢组织内卵泡形态学、卵巢组织混悬液中卵泡计数和卵巢皮质培养上清液的雌二醇(E_(2))水平。结果(1)组织学分析:两冷冻组卵巢皮质中始基卵泡完整率明显低于新鲜对照组(84.62%、80.21%vs.97.93%,P<0.001),但两冷冻组之间差异均无统计学意义(P>0.05);程序化冷冻组次级卵泡完整率明显低于新鲜对照组(37.5%vs.88.24%,P<0.05);(2)窦前卵泡的计数:玻璃化冷冻组和程序化冷冻组单位体积卵巢组织混悬液中始基卵泡计数均明显低于新鲜对照组[(76.50±8.91)&(79.67±10.40)vs.(91.50±8.70),P=0.001];程序化冷冻组每100μL卵巢组织混悬液中初级卵泡和次级卵泡计数均明显低于新鲜对照组[(22.83±3.74)vs.(27.33±3.02),(9.50±3.46)vs.(12.55±3.25),P<0.05];(3)卵巢组织培养液中的E_(2)水平:体外培养的初期阶段(D2⁃D6),冻融卵巢组织分泌的E_(2)水平低于新鲜组织(P<0.05),之后阶段各组间上清液E_(2)水平差异无统计学意义(P>0.05)。结论玻璃化冷冻和程序化冷冻均能有效地保存人卵巢组织的活性;玻璃化冷冻方法简单易行,对于次级卵泡的保存效果优于程序化冷冻组,更适合人卵巢组织的冷冻保存。 Objective To investigate the effects of vitrification and programmed cryopreservation on human ovarian cortex.Methods Ovarian tissue samples were collected from patients with ovarian disease and were randomly divided into vitrification freezing group,programmed freezing group and control group.We carried out histological analysis of ovarian tissue,isolation and counting of preantral follicles,and in vitro culture of ovarian cortex.The follicle morphology of ovarian tissue,the number of follicles in suspension of ovarian tissue and the estradiol level in the supernatant of ovarian cortical culture were compared among the three groups.Results(1)The intact rate of primordial follicles in the ovarian cortex of the two freezing groups was significantly lower than that of the control group(84.62%&80.21%vs.97.93%,P<0.001),but there was no statistical significance between the two freezing groups(P>0.05).Normal rate of secondary follicles in programmed freezing group was significantly lower than that in the control group(37.5%vs.88.24%,P<0.05).(2)The number of primary follicles in suspension of ovarian tissue per unit volume in two freezing groups was significantly lower than that in the control group[(76.50±8.91)&(79.67±10.40)vs.(91.50±8.70),P=0.001].There were significant differences in the number of primary follicles and secondary follicles in the 100 microliters in suspension of ovarian tissue between programmed freezing group and the control group[(22.83±3.74)&(9.50±3.46)vs.(27.33±3.02)&(12.55±3.25),P<0.05].(3)At the initial stage of in vitro culture(D2⁃D6),the level of E_(2) secreted by freeze⁃thawing tissue was lower than that of fresh tissue(P<0.05),and there was no statistical significance in the E_(2) level of supernatant among each group(P>0.05).Conclusion Both vitrification and programmed freezing can effectively preserve the activity of ovarian tissue.The vitrification method is more effective in preserving secondary follicles than the programmed method,and it is simple and easy to operate,which is more suitable for cryopreservation of ovarian tissue.
作者 刘艳丽 申峻涵 杜姗姗 刘景 申春艳 肖小帅 管一春 LIU Yanli;SHEN Junhan;DU Shanshan;LIU Jing;SHEN Chunyan;XIAO Xiaoshuai;GUAN Yichun(Reproductive Medicine Center,the Third Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China)
出处 《实用医学杂志》 CAS 北大核心 2021年第24期3202-3207,共6页 The Journal of Practical Medicine
基金 河南省医学科技攻关计划联合共建项目(编号:2018020181)。
关键词 玻璃化冷冻 程序化冷冻 卵巢皮质 卵泡活性 vitrification programmed cryopreservation ovarian cortex follicle activity
  • 相关文献

参考文献2

二级参考文献38

  • 1Donnez J, Dolmans MM, Pellicer A, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation [J]. Fertil Steril, 2013,99(6):1503-1513.
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009 [J]. CA Cancer J Clin, 2009,59(4) : 225-249.
  • 3Lee S J, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients [ J ]. J Clin Oncol, 2006,24 ( 18 ) : 2917-2931.
  • 4Falcane T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy [J]. Curr Opin Obstet Gynecol, 2005, 17(1) :21-26.
  • 5Georgescu ES, Goldberg JM, du Plessis SS, et al. Present and future fertility preservation strategies for female cancer patients [ J ]. Obstet Gynecol Surv, 2008,63 ( 11 ) : 725-732.
  • 6Manger K, Wildt L, Kalden JR, et al. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study [J]. Autoimmun Rev, 2006,5 (4) : 269-272.
  • 7Gidoni Y, Holzer H, Tulandi T, et al. Fertility preservation in patients with non-oncological conditions [J ]. Reprod Biomed Online, 2008,16(6) :792-800.
  • 8Elizur SE, Cbian RC, Pinean CA, et al. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents[J]. Rheumatology (Oxford), 2008,47(10) : 1506-1509.
  • 9Loren AW, Mangu PB, Beck LN, et al. Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update [ J ]. J Clin Oncol, 2013,31 (19) :2500-2510.
  • 10Partridge A, Gelber S, Gelber RD, et al. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI [J]. Eur J Cancer, 2007, 43(11) : 1646-1653.

共引文献6

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部